LivingGLP1
Study S001084

A Randomized Clinical Trial of Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

Registration

Registration
NCT07573163
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
NONE
Status
RECRUITING
Enrollment
34
Start
2026-07-27
Primary completion
2028-07-31
Lead sponsor
Alaa Sada
Conditions
Mild Autonomous Cortisol Secretion (MACS); Adrenalectomy; Status
Interventions
DRUG:Tirzepatide; OTHER:Standard medical treatment
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in systolic blood pressure [Baseline and 12 months]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0018082Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial.
Krumholz HM, Heart (British Cardiac Society)
2024Randomized trialPMID 39084707DOIregistry reference BACKGROUND:39084707
R0019593Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials.
Kanbay M, Diabetes, obesity & metabolism
2023Systematic reviewPMID 37700437DOIregistry reference BACKGROUND:37700437